Tony Butler
Stock Analyst at Rodman & Renshaw
(0.93)
# 3,729
Out of 4,876 analysts
105
Total ratings
31.37%
Success rate
-14.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $7.95 | +214.47% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.29 | +380.35% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.99 | +804.52% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.47 | +507.29% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.28 | +2,760.21% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.57 | +2,718.89% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.24 | +4,028.82% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.10 | +809.09% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $46.70 | +60.60% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $53.18 | -34.19% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $3.80 | +1,478.95% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.63 | +697.55% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.28 | +586.81% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.20 | +1,150.00% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.38 | +6,564.89% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.18 | +1,171.19% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.44 | +309.84% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.43 | +1,088.81% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.91 | +3,280.86% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $9.46 | +534.25% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.16 | +11,011.11% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.87 | +591.24% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.22 | +8,430.81% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.00 | -33.33% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.05 | +392.61% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.46 | +584.93% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.60 | +476.92% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $9.61 | +1,044.64% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.46 | +17,291.30% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $7.95
Upside: +214.47%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.29
Upside: +380.35%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.99
Upside: +804.52%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.47
Upside: +507.29%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.28
Upside: +2,760.21%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.57
Upside: +2,718.89%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.24
Upside: +4,028.82%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.10
Upside: +809.09%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $46.70
Upside: +60.60%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $53.18
Upside: -34.19%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $3.80
Upside: +1,478.95%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.63
Upside: +697.55%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.28
Upside: +586.81%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.20
Upside: +1,150.00%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.38
Upside: +6,564.89%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.18
Upside: +1,171.19%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $2.44
Upside: +309.84%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.43
Upside: +1,088.81%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.91
Upside: +3,280.86%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $9.46
Upside: +534.25%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.16
Upside: +11,011.11%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.87
Upside: +591.24%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.22
Upside: +8,430.81%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.00
Upside: -33.33%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.05
Upside: +392.61%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.46
Upside: +584.93%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.60
Upside: +476.92%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $9.61
Upside: +1,044.64%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.46
Upside: +17,291.30%